Chemical industry – Page 60
-
Business
Daiichi Sankyo awarded damages from former Ranbaxy owners
Arbitration says Singh family withheld information about regulatory investigations during Ranbaxy takeover
-
Business
Abbot boosts heart devices with St Jude buyout
Medical devices consolidation continues with $25bn deal, but Abbott expresses concerns over proposed Alere merger
-
Business
Cancer deals spread
AbbVie nabs antibody specialist Stemcentrx, while Sanofi pursues Medivation
-
Business
Chemours sheds disinfectants and aniline
Dow Chemical and Germany’s Lanxess will buy plants as Chemours restructures following its spin-off from DuPont
-
Business
Pumping up industrial wasted heat
Company profile: Qpinch reclaims wasted energy by mimicking nature
-
Business
FDA moves to withdraw swine drug carbadox
Carcinogenic antibiotic has been banned in EU, Canada and Australia for years
-
Business
Surge in US industry investment linked to shale gas
264 expansion or construction projects announced, of which 40% have commenced or completed
-
Business
US treasury rules scupper Pfizer–Allergan merger
Government aims to crack down on corporate tax avoidance through ‘inversion’ deals
-
Business
DuPont shutters US plant where leak killed four workers
La Porte plant will not reopen after fatal methyl mercaptan leak in 2014
-
Business
Californian hazard warning website criticised
Site providing information related to state’s Proposition 65 law is ‘inaccurate’ says industry association
-
Business
Two dead in explosion at Chinese chemical plant
Five others injured when wastewater treatment device detonated
-
Opinion
Throwing things over the fence
Saying ‘That’s someone else’s problem’ is asking for trouble, says Derek Lowe
-
Business
Gilead loses to Merck & Co in hepatitis C drug dispute
US court upholds Merck’s claim to patents related to blockbuster drugs
-
Business
MEGlobal to build $1bn US petrochemical plant
Ethylene glycol company announces plans for first US facility
-
Business
Indian whistleblower pushes for regulatory reform
Although denied a hearing by India’s supreme court, Dinesh Thakur wants to shake up pharmaceutical safety laws
-
Feature
Enzymes for everyone
Can scientists overcome enzymes’ fragility and exploit their speed and specificity? Fiona Case investigates
-
Business
Roche sketches out Blueprint collaboration
Drug discovery startup will contribute to cancer immunotherapy projects aimed at kinase enzymes
-
Business
India bans 344 combination drugs
Manufacturers appeal to courts to allow continued sales of products the government deems risky
-
Business
Sanction lift triggers investment in Iran
Ambitious state plans and openness to foreign companies could combine to revive Iran’s chemical industry
-
Opinion
Drugs don’t grow on trees
The trope of companies profiteering from academic discoveries doesn’t bear much scrutiny, says Derek Lowe